Non Executive Director & Scientific Advisor

Dr Yacine Hadjiat holds a medical degree with a specialization in Pain Management, as well as an MBA in Healthcare Management. He has also completed several trainings and specializations in cancer care, clinical research, health economics, public health & health policy, and technology in healthcare.

Throughout his career, he has held several global senior executive leadership positions in the life-science industry such as Chief Medical Officer, General Manager, and Global Head of Digital Health Solutions based across Europe, US, MEA, and Asia.

Along with his career in the Life Science industry, Dr Hadjiat has several years of clinical practice and clinical research experience, has held advisory and board roles for governmental agencies, startups, and VCs, and has also been deeply engaged in Innovation and Digital health education and research in both Medical Universities and Business Schools.

Global Scientific Lead

Ernestine has around 10 years of experience in the pharmaceutical industry of which 5 years were spent in the Medical Communications space working closely with top pharmaceutical companies supporting the development and implementation of their medico-marketing and publication strategies.

Following this, Ernestine served as Regional Medical Affairs Manager for Mundipharma’s Asia Pacific, Middle East, Africa and Latin America (APAC-MEA-LAM) region. Here, she was responsible for the development and implementation of regional medico-marketing strategies and initiatives and successfully expanded the company’s scientific footprint, and strengthened the portfolio value proposition. In her role, she also provided medical evaluation of potential molecules, device and digital solutions for acquisition, co-marketing or in-licensing for portfolio expansion. During this time, she also successfully supported negotiations in Asia Pacific for big distribution/promotion deals with other MNCs.

In 2020, Ernestine joined Kreivo Health as an Executive Project Manager where she currently supports the establishment and expansion of healthcare companies in Asia Pacific and other parts of the world.

Global Commercial Lead

Vesper has around 9 years of experience in the healthcare industry, specializing in B2B partnerships, market evaluation, and go-to-market strategy for healthcare companies. She has a proven track record in identifying high-potential markets, building strategic alliances, and accelerating market entry through effective sales, marketing, and regulatory navigation.

At Mundipharma and MSD in Asia, Vesper delivered significant growth while identifying breakthrough market opportunities and launching strategic marketing initiatives to ensure long-term, sustainable expansion. While supporting healthcare companies, she spearheaded B2B commercialization initiatives, forging key partnerships with distributors, KOLs, and healthcare providers, ensuring swift market access and long-term business sustainability.

With a strong ability to align commercial goals with market realities, Vesper has played a pivotal role in accelerating international expansion for healthcare companies through strategic B2B partnerships, effective alliance management, resources allocation and market execution.

Regulatory and Scientific Affairs Lead

Severine is a Doctor of Pharmacy with a master’s degree in Regulatory Affairs. She has also completed post-graduate diplomas in pharmacovigilance and pharmacoepidemiology, and in immunology.

Severine has around 15 years of experience working in regulatory affairs in several MNCs, across Europe and Asia, covering the entire product lifecycle, from the development phase to post-approval activities, for small molecules as well as biologics. During this time, she held various roles at national, regional and global level, conducting multiple submissions and defining insightful regulatory strategies. As part of her regulatory career, she successfully supported the registration and subsequent launch of a first-in-class product, managed a full manufacture and license transfer and led a major conformance project up to completion.

Severine also worked as a clinical assessor at the French National Agency for the Safety of Medicines and Health Products (ANSM), where she had the opportunity to act as a national appointed expert at a CMDh meeting.

MEA Lead

Hamza has 17 years experience in commercial leadership, marketing, and operations within the pharmaceutical industry. His career journey boasts significant contributions to big and mid-size pharmaceutical organizations, alongside ventures into biotechnology, medical devices, and OTC sectors. Hamza's expertise extends to both establishing companies from the ground up and driving impactful transformations across diverse markets and business models.